Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1175 results found. Search for [ Pharma industry ]

Results 1160 to 1175 of 1175
By Ritwik Mukherjee
October 3, 2007
The ICAI mulls industry-specific accounting norms.


By E. Kumar Sharma
September 24, 2007
The excitement and glamour of advertising is luring professionals from the unlikeliest of fields. Dumping their “safe” jobs and (often) better remunerations, doctors, IT consultants, hospitality industry professionals and rural marketers are all heading to the organised chaos of advertising.


By Rahul Sachitanand
September 24, 2007
Listings are horribly hard to put together. This one is more so. For one, how does one measure power? For another, when there are so many talented and successful women in Indian business, how does one zero in on the 25 most powerful? The first question is relatively easy to answer.


By Mahesh Nayak
September 11, 2007
Strikes five deals worth $840 million in 12 months.


By Mukul Rai
September 10, 2007
India will have to work hard to maintain its lead over China in New Economy sectors.


By Kapil Bajaj
August 31, 2007
They grow fast and often provide multi-bagger returns for investors. Here's how to profit from them.


By Mahesh Nayak
August 31, 2007
With new industries and businesses taking off, the war for top management talent has pushed CEO salaries to record levels. But the fact is, not every CEO is getting paid obscenely and certainly not as much as what some CEOs in the US take home.


By Rahul Sachitanand
August 30, 2007
As scale becomes critical, the bigger BPOs are bulking up by buying captives and other smaller outfits. And like in IT, the top three companies may become the dominant force.


By E. Kumar Sharma
August 29, 2007
Potential for CRAMS is huge, but where's the manpower?


By Balaji Chandramouli and Aman Malik
August 29, 2007
Generic drugs will continue to dominate the Indian pharma market over the next five years, but multinational companies are lobbying to shape patent laws to protect their profitability over the long term. How far will they succeed?


By E. Kumar Sharma
August 29, 2007
A McKinsey report projects $20 bn in revenues by 2015.


By E. Kumar Sharma
August 17, 2007
When Dr Reddy's labs announced last fortnight that its anti-diabetic molecule Balaglitazone had entered phase III clinical trials, it was easily one of the highest points of the Indian pharma sector's research & development (R&D) programme in a long time.


By Krishna Gopalan
August 16, 2007
As state capitals get crowded, businesses are scrambling for newer destinations within and outside their home states. Happily for India Inc., there are quite a few cities to choose from.


By Anand Adhikari
August 13, 2007
It has nudged ahead of the competition in the foreign banks arena, but there's more to Citigroup in India than just banking.


By Venkatesha Babu
August 10, 2007
With enzymes sold off, Biocon goes pure bio-pharma.


By Balaji Chandramouli and Aman Malik
July 16, 2007
The traditional suitcase-style lobbyist is alive and kicking, but the deregulated economy has spawned a new variety that believes in using 'case law-style' advocacy to effect policy changes.


PAGES 59 OF 59  56575859